Your Expert Guide to Developing Psychoactive Substances

Practical Approaches to Conducting
​​​​​Early Clinical Trials with Psychedelics

Watch this on-demand webinar on the development of psychedelics. Altasciences’ experts, Dr. Setnik and Dr. Milovan, provide an overview of the pragmatic and cost-effective approaches to conducting early-phase clinical trials with psychedelics, including adequate setup of the clinical pharmacology unit.


Speak with our experts to discuss your drug development needs.​

You may also be interested in the following:


CNS Clinical Trials

Human Abuse Potential

Scientific Journal: Challenges Associated with Schedule I Therapeutic Development 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.